secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0000950170-23-043554
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix's KidneyIntelX included in draft KDIGO 2023 chronic kidney disease guidelines
--------------------------------------------------------------------------------

- Public comment period on draft KDIGO 2023 guidelines closed; final version expected Q4 2023.
- KDIGO is a global nonprofit; guidelines are followed by clinicians worldwide.
- Inclusion, if finalized, could drive broader adoption and reimbursement for KidneyIntelX in US and abroad.
- Renalytix notes inclusion in draft does not guarantee inclusion in final guidelines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023043554/0000950170-23-043554-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023043554/rnlx-20230821.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-043554

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer